Saleema Kherani, Akhila Alapati, Tedi Begaj, Samantha Atlas, Anjum Koreishi, Timothy Janetos, Lisa J Faia, Debra A Goldstein
求助PDF
{"title":"Efficacy of Subcutaneous and Intravenous Tocilizumab in Noninfectious Uveitis.","authors":"Saleema Kherani, Akhila Alapati, Tedi Begaj, Samantha Atlas, Anjum Koreishi, Timothy Janetos, Lisa J Faia, Debra A Goldstein","doi":"10.1016/j.ophtha.2024.10.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":null,"pages":null},"PeriodicalIF":13.1000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ophtha.2024.10.010","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
皮下注射和静脉注射托昔单抗治疗非感染性葡萄膜炎的疗效
这项回顾性研究调查了皮下注射和静脉注射托珠单抗(TCZ)治疗葡萄膜炎的成功率。总体而言,在随访12个月的患者中,74.0%的患者在1年后取得了治疗成功(皮下注射77.8%,静脉注射72.2%)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。